Atlas Trials

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Clinical trial NCT07164430 · COMPLETED

Trial details

NCT number
NCT07164430
Sponsor
Nicola Irwin
Status
COMPLETED
Study type
OBSERVATIONAL
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Start date
2025-09-22
Primary completion
2026-01-31
Enrollment
2792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.